MICRO-X LIMITED — Capital/Financing Update 2025

Feb 17, 2025

18 February 2025

20 Bridge Street Sydney NSW 2000

By electronic lodgement

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)

Micro-X Limited ACN 153 273 735 ( Company ) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Act ) that:

• (a) on 18 February 2025, it issued 25,742,859 fully paid ordinary shares to sophisticated and professional investors – these shares were issued for cash consideration of $0.07 per share;

• (b) the shares referred to above were issued without disclosure under Part 6D.2 of the Act;

• (c) as at the date of this notice, the Company has complied with:

• (i) the provisions of Chapter 2M of the Act as they apply to the Company; and

• (ii) section 674 and 674A of the Act; and

• (d) as at the date of this notice, there is no “excluded information” of the type referred to in sections 708A(7) and 708A(8) of the Act.

Release authorised by the Board of Micro-X Limited.

Yours sincerely

==> picture [167 x 46] intentionally omitted <==

Kingsley Hall Chief Executive Officer and Company Secretary Micro-X Limited

Micro-X Ltd. ABN 21 153 273 735, 1284 South Road, MAB Gate 2, Tonsley, South Australia 5042 ww.micro-x.com

About Micro-X

Micro-X Limited (the Company ) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has a fully vertically integrated design and production facility in Adelaide, Australia. A growing technical and commercial team based in Seattle is rapidly expanding Micro-X’s US business.

radiology products are currently sold for diagnostic imaging in global healthcare, military and veterinary applications and the Argus X-ray Camera for security and defence is now commercially available. The US Department of Homeland Security has contracted Micro-X to design a next-generation Airport security checkpoint. A miniature brain CT imager for pre-hospital stroke diagnosis in ambulances, is being developed with funding from the Australian Government’s Medical Research Future Fund.

For more information visit: www.micro-x.com

CONTACTS

Micro-X Limited	Investor Enquiries
Kingsley Hall, Chief Executive Ofcer Rebecca Puddy, Head of Corporate Communications Tel: +61 8 7099 3966 E: media@micro-x.com	David Allen / John Granger Hawkesbury Partners Tel: +61 2 9103 9494 E: dallen@hawkesburypartners.com jgranger@hawkesburypartners.com

Micro-X Ltd. ABN 21 153 273 735, 1284 South Road, MAB Gate 2, Tonsley, South Australia 5042 ww.micro-x.com